NZ Skin Cancer Research Review Issue 7

In this issue:

First-line BRAF/MEK inhibitors vs. anti-PD-1 for BRAF V600-mutated advanced melanoma
High discordance rate in sentinel node positivity in cutaneous melanoma
Carboplatin + paclitaxel ±bevacizumab in untreated advanced mucosal melanoma
Genital premalignant and malignant diseases
Validation of AJCC metastatic cutaneous melanoma staging for ICI treatment
Clinical size is a poor predictor of invasion in lentigo maligna
Neoadjuvant ipilimumab +  nivolumab in synchronous stage III melanoma
Predicting local, regional and distant recurrence of thin melanomas
ICIs for melanoma with preexisting autoimmune disease
Association between surgical margins >1cm and OS in MCC

Please login below to download this issue (PDF)